Ivan V. Inigo
Impact in
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Chronic Myeloid Leukemia Treatments 5
- Oncology 5
- Cancer Immunotherapy and Biomarkers 4
- HER2/EGFR in Cancer Research 1
- Co-authors
- Stephen Castaneda (8 shared papers)Amy Camuso (10 shared papers)Christine Flefleh (10 shared papers)Kelly McGlinchey (9 shared papers)Krista Fager (10 shared papers)David Kan (10 shared papers)Francis Y. Lee (9 shared papers)Robert A. Kramer (8 shared papers)
- Journals
- Blood (4 papers)Molecular Cancer Therapeutics (3 papers)Cancer Research (3 papers)Clinical Cancer Research (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
- Partner nations
- United States
In The Last Decade
Ivan V. Inigo
19 papers receiving 1.9k citations
Ivan V. Inigo's Hit Papers
Peers
Comparison fields: 5 of 61
- Hematology 384
- Oncology 265
- Genetics 49
- Immunology 68
- Computational Theory and Mathematics 48
Countries citing papers authored by Ivan V. Inigo
This map shows the geographic impact of Ivan V. Inigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan V. Inigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan V. Inigo more than expected).
Fields of papers citing papers by Ivan V. Inigo
This network shows the impact of papers produced by Ivan V. Inigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan V. Inigo. The network helps show where Ivan V. Inigo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan V. Inigo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Discovery of N -(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays Hit paper breakdown → | 2004 | 1141 |
| 2 | Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade Hit paper breakdown → | 2018 | 288 |
| 3 | 2006 | 125 | |
| 4 | 2005 | 73 | |
| 5 | 2006 | 61 | |
| 6 | 2020 | 61 | |
| 7 | 2013 | 49 | |
| 8 | BMS-354825 potently inhibits multiple selected oncogenic tyrosine kinases and possesses broad-spectrum antitumor activities in vitro and in vivo | 2005 | 38 |
| 9 | 2005 | 23 | |
| 10 | 2018 | 22 | |
| 11 | 2005 | 21 | |
| 12 | 2022 | 18 | |
| 13 | 2005 | 17 | |
| 14 | 2020 | 15 | |
| 15 | 2004 | 10 | |
| 16 | Pharmacodynamic analysis of target inhibition and tumor endothelial cell death in biopsies obtained from patients treated with the VEGF receptor antagonists SU5416 or SU6668 | 2004 | 5 |
| 17 | 2005 | 5 | |
| 18 | 2004 | 2 | |
| 19 | BMS-536924, a potent, small molecule inhibitor of the IGF-1 receptor in vitro and in vivo | 2005 | 2 |
About Ivan V. Inigo
Ivan V. Inigo is a scholar working on Hematology, Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Organic Chemistry, having authored 19 papers that have together received 2.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Synthesis and biological activity (1 paper), Protein Kinase Regulation and GTPase Signaling (1 paper), Cell death mechanisms and regulation (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Growth Hormone and Insulin-like Growth Factors (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Hematology (384 citations), Oncology (265 citations), Genetics (49 citations), Immunology (68 citations) and Computational Theory and Mathematics (48 citations). Ivan V. Inigo has collaborated with scholars based in United States. Frequent co-authors include Stephen Castaneda, Amy Camuso, Christine Flefleh, Kelly McGlinchey, Krista Fager, David Kan, Francis Y. Lee, Robert A. Kramer, David Schaer and Michael D. Kalos. Their work appears in journals such as Blood, Molecular Cancer Therapeutics, Cancer Research, Clinical Cancer Research and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.